IRIS
RAVAGLIA, SABRINA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.451
AS - Asia 1.849
EU - Europa 1.777
SA - Sud America 225
AF - Africa 60
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.370
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.407
CN - Cina 869
SG - Singapore 424
IE - Irlanda 372
IT - Italia 291
DE - Germania 229
HK - Hong Kong 220
FI - Finlandia 201
RU - Federazione Russa 189
VN - Vietnam 181
UA - Ucraina 173
BR - Brasile 162
GB - Regno Unito 100
FR - Francia 81
IN - India 37
SE - Svezia 36
ZA - Sudafrica 31
CA - Canada 24
BD - Bangladesh 20
AR - Argentina 17
BE - Belgio 17
EC - Ecuador 16
JP - Giappone 16
NL - Olanda 16
PL - Polonia 14
ES - Italia 13
MX - Messico 12
IQ - Iraq 10
MA - Marocco 10
PK - Pakistan 10
CL - Cile 7
CO - Colombia 7
AT - Austria 6
ID - Indonesia 6
MY - Malesia 6
AU - Australia 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
LT - Lituania 5
TN - Tunisia 5
TR - Turchia 5
VE - Venezuela 5
AL - Albania 4
ET - Etiopia 4
GR - Grecia 4
JO - Giordania 4
KR - Corea 4
PE - Perù 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
PH - Filippine 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
AZ - Azerbaigian 2
EG - Egitto 2
KW - Kuwait 2
OM - Oman 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 6.370
Salva come PNG Salva come JPEG
Città #
Chandler 376
Dublin 369
Singapore 257
Ashburn 231
Dallas 220
Hong Kong 213
San Jose 210
Jacksonville 206
Beijing 186
Nanjing 164
Boardman 117
Helsinki 79
Munich 73
Los Angeles 70
Milan 68
Ho Chi Minh City 67
Nanchang 60
Lauterbourg 53
Ann Arbor 52
Jiaxing 52
Pavia 52
Changsha 50
Lawrence 50
Princeton 50
Medford 49
Hebei 48
New York 45
Hanoi 44
Shenyang 41
Wilmington 41
Shanghai 35
Buffalo 34
Hangzhou 32
Turku 30
Johannesburg 28
Moscow 28
Tianjin 21
Frankfurt am Main 19
Brussels 17
London 17
São Paulo 17
Redondo Beach 16
Tokyo 16
Trieste 14
Verona 14
Orem 13
Toronto 13
Warsaw 13
Bergamo 12
Amsterdam 10
Da Nang 10
Seattle 10
The Dalles 10
Turin 10
Woodbridge 10
Atlanta 9
Brooklyn 9
Denver 9
Manchester 9
San Francisco 9
Chicago 8
Cagliari 7
Chennai 7
Dhaka 7
Falkenstein 7
Houston 7
Montreal 7
Nuremberg 7
Poplar 7
Pune 7
Rome 7
Santa Clara 7
Stockholm 7
Biên Hòa 6
Charlotte 6
Gorlago 6
Kunming 6
Lahore 6
Lodi 6
Modena 6
Norwalk 6
Piscataway 6
Belo Horizonte 5
Bologna 5
Boston 5
Brno 5
Columbus 5
Fairfield 5
Florence 5
Haiphong 5
Mexico City 5
Monza 5
Quito 5
Travaco Siccomario 5
Zhengzhou 5
Addis Ababa 4
Athens 4
Baghdad 4
City of London 4
Como 4
Totale 4.318
Salva come PNG Salva come JPEG
Nome #
Mapping the human genetic architecture of COVID-19 289
A first update on mapping the human genetic architecture of COVID-19 189
A Chaperone Enhances Blood α-Glucosidase Activity in Pompe Disease Patients Treated With Enzyme Replacement Therapy. 159
Changes in nutritional status and body composition during enzyme replacementtherapy in adult-onset type II glycogenosis. 141
Dietary treatment in adult-onset type II glycogenosis. 135
Enzyme replacement therapy (ERT) in adult-onset type II glycogenosis (GSDII) 133
Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant. 133
Cognitive impairment and central motor conduction time in chronic alcoholics. 127
Severe recurrent myelitis in patients with hepatitis C virus infection 118
Recombinant alpha-glucosidase in adult-onset type II glycogenosis: The experience with the first Italian patient, from expanded access programmes to marketing authorization 116
Clinical MRI dissociation in myelopathy: a clue to sarcoidosis? 116
Bioimpedance Phase Angle as a Prognostic Tool in Late-Onset Pompe Disease: A Single-Centre Prospective Study With a 15-year Follow-Up 115
Aspetti clinici e patogenetici della comorbidita’ emicranica. 115
Early-onset ptosis in type II glycogenosis 114
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 114
Adult-onset type II glycogenosis (GSDII): Clinical spectrum and enzyme replacement therapy (ERT) 113
Guillain-Barré syndrome associated with SARS-CoV-2 113
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patientswith Alzheimer's disease and vascular dementia. 112
Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD) 111
The angiotensin-converting enzyme insertion/deletion polymorphysm modifies the clinical outcome in patients with Pompe disease. 110
Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response. 109
Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encphalomyelitis. 107
Genotype-phenotype correlation in Pompe disease, a step forward. 107
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 104
Severe recurrent myelitis in patients with hepatitis C virus infection patients 103
Immune-mediated neuropathies in myeloma patients treated with bortezomib. 103
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants 103
Combined central and peripheral demyelination: comparison of adult and pediatric series 102
Strabismo parossistico: Meccanismi corticali e meccanismi periferici nella fisiopatologia di due casi con analoga fenomenologia critica 102
Can genes influencing muscle function affect the therapeutic response to enzyme replacement therapy (ERT) in late-onset Type II Glycogenosis? 101
Enzyme replacement therapy in severe adult-onset glycogen storage disease type II 101
Emicrania emiplegica familiare: dalla genetica alla clinica. 99
Recombinant alglucosidase alpha (rhGAA) in adult-onset type II glycogenosis (GSDII): A follow-up study before and after treatment 98
Triggering migraine attacks:the role of nitroderivatives. 98
Efficacy of propafenone in paramyotonia congenita 97
NMO-IgG-negative relapsing myelitis 97
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 97
Pathogenetic role of myelitis for syringomyelia. 96
Outcome after Two Years of Enzyme Replacement Therapy (ERT) in 29 Patients with Late-Onset Type II Glycogenosis (GSDII) 95
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 92
Enzyme replacement therapy in adult-onset type II glycogenosis 91
RECOMBINANT ALGLUCOSIDASE ALFA IN ADULT-ONSET GLYCOGENOSIS TYPE II: A FOLLOW-UP STUDY BEFORE AND AFTER TREATMENT 88
Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? 87
Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease. 87
Erratum: Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (Journal of Neurology (2014) 261 (438-440) DOI: 10.1007/s00415-013-7217-3) 86
Presyrinx in children with Chiari malformations 84
HaNDL syndrome: a reversible cerebral vasoconstriction triggered by an infection? A case report and a case-based review 79
Retinal migraine as unusual feature of cerebral autosomal dominantarteriopathy with subcortical infarcts and leukoencephalopathy(CADASIL) 78
Ocular neuromyotonia with both tonic and paroxysmal components due to vascular compression 77
Trunk muscle involvement in late-onset Pompe disease: Study of thirty patients 76
Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? 73
Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. 73
Enzyme replacement therapy in late-onset type II glycogenosis. 72
Erectile dysfunction as a sentinel symptom ofcardiovascular autonomic neuropathy in heavy drinkers 70
The diagnosis of migraine: clinical and instrumental aspects 69
ENZYME REPLACEMENT THERAPY IN LATE-ONSET PHENOTYPES OF GLYCOGENOSIS TYPE 2: RESULTS OF AN ITALIAN MULTICENTER STUDY 68
Familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2 68
Post-infectious and postvaccinal acute disseminated encephalomyelitis occurring in the same patients 67
Post-infectious inflammatory disordes:sub-groups based on prospective follow-up. 66
Severe steroid-resistant post-infectious encephalomyelitis: General features and effects of IVIg 66
Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful? 58
COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up 54
Enzyme replacement therapy with Alglucosidase alfa in juvenile-adult glycogenosis type 2 patients 54
null 34
Guillain‐Barré syndrome and COVID‐19: A 1‐year observational multicenter study 27
Totale 6.436
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.155
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 40 36 7
2021/2022221 5 3 4 3 0 4 3 11 11 2 36 139
2022/20231.202 84 90 12 174 97 123 2 61 438 13 96 12
2023/2024398 49 73 11 18 28 102 5 26 5 10 19 52
2024/20251.113 34 96 60 31 35 74 68 51 248 42 105 269
2025/20262.163 209 203 260 220 286 109 452 91 232 101 0 0
Totale 6.436